The effect of ischemic cholinergic damage on cognition in patients with subcortical vascular cognitive impairment

Journal of Geriatric Psychiatry and Neurology

Volumn 25, Issue 2, 2012, Pages 122-127

  Kim, Sook Hui ^a   Kang, Hyun Seok ^b   Kim, Hee Jin ^a   Moon, Yeonsil ^a   Ryu, Hui Jin ^a   Kim, Min Young ^a   Han, Seol Heui ^a  

^a Konkuk University Hospital   (South Korea)

^b Bundang Jesaeng Hospital   (South Korea)

Author keywords

cholinergic pathway; Cholinergic Pathway HyperIntensity Scale (CHIPS); subcortical vascular cognitive impairment; white matter hyperintensity

Indexed keywords

AGED; ARTICLE; BRAIN ISCHEMIA; CHOLINERGIC PATHWAY HYPERINTENSITY SCALE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; CORRELATION ANALYSIS; DEMENTIA; DISEASE SEVERITY; FEMALE; HUMAN; INTERRATER RELIABILITY; INTRARATER RELIABILITY; MALE; MILD COGNITIVE IMPAIRMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; SCHELTEN SCALE; SEMANTICS; SUBCORTICAL VASCULAR MILD COGNITIVE IMPAIRMENT; WHITE MATTER;

AGED; AGED, 80 AND OVER; BRAIN; BRAIN ISCHEMIA; CHOLINERGIC NEURONS; COGNITION; COGNITION DISORDERS; DEMENTIA, VASCULAR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 84862245225     PISSN: 08919887     EISSN: 15525708     Source Type: Journal    
DOI: 10.1177/0891988712445089     Document Type: Article

References (39)

1. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol. 1986; 19(3):253-262. (Pubitemid 16111074)
2. Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43(9):1683-1689. (Pubitemid 23307935)
3. Breteler MM, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam study. Neurology. 1994; 44(7):1246-1252. (Pubitemid 24232223)
4. Streifler JY, Eliasziw M, Benavente OR, et al. Development and progression of leukoaraiosis in patients with brain ischemia and carotid artery disease. Stroke. 2003;34(8):1913-1916. (Pubitemid 36944780)
5. Mirsen TR, Lee DH, Wong CJ, et al. Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain. Arch Neurol. 1991;48(10):1015-1021.
6. Debette S, Bombois S, Bruandet A, et al. Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment. Stroke. 2007;38(11):2924-2930. (Pubitemid 350041561)
7. Fazekas F, Kapeller P, Schmidt R, et al. The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer's disease. J Neurol Sci. 1996;142(1-2):121-125. (Pubitemid 26340420)
8. Kim SH, Park JS, Ahn HJ, et al. Voxel-based analysis of diffusion tensor imaging in patients with subcortical vascular cognitive impairment: correlates with cognitive and motor deficits. J Neuroimaging. 2011;21(4):317-324.
9. Gootjes L, Teipel SJ, Zebuhr Y, et al. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging. Dement Geriatr Cogn Disord. 2004; 18(2):180-188. (Pubitemid 39140369)
10. Chen YF, Wang H, Chu Y, Huang YC, Su MY. Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease. Dement Geriatr Cogn Disord. 2006;22(2):177-184. (Pubitemid 44253215)
11. Selden NR, Gitelman DR, Salamon-Murayama N, Parrish TB, Mesulam MM. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain. 1998; 121(pt 12):2249-2257. (Pubitemid 28552464)
12. Tohgi H, Abe T, KimuraM, SahekiM, Takahashi S. Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. J Neural Transm. 1996;103(10):1211-1220. (Pubitemid 26381982)
13. Roman GC. Cholinergic dysfunction in vascular dementia. Curr Psychiatry Rep. 2005;7(1):18-26. (Pubitemid 40485475)
14. Roman GC, Kalaria RN. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol Aging. 2006;27(12):1769-1785. (Pubitemid 44572575)
15. Nardone R, Bergmann J, Tezzon F, Ladurner G, Golaszewski S. Cholinergic dysfunction in subcortical ischaemic vascular dementia: a transcranial magnetic stimulation study. J Neural Transm. 2008;115(5):737-743.
16. Swartz RH, Sahlas DJ, Black SE. Strategic involvement of cholinergic pathways and executive dysfunction: does location of white matter signal hyperintensities matter? J Stroke Cerebrovasc Dis. 2003;12(1):29-36. (Pubitemid 36292855)
17. van de Pol LA, Korf ES, van der Flier WM, et al. Magnetic resonance imaging predictors of cognition in mild cognitive impairment. Arch Neurol. 2007;64(7):1023-1028. (Pubitemid 47048004)
18. Seo SW, Cho SS, Park A, et al. Subcortical vascular versus amnestic mild cognitive impairment: comparison of cerebral glucose metabolism. J Neuroimaging. 2009;19(3):213-219.
19. American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed. Washington, DC: American Psychiatric Press; 1994.
20. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351-356. (Pubitemid 17104996)
21. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303-308. (Pubitemid 29120227)
22. Ku HM, Kim JH, Kwon EJ, et al. A study on the reliability and validity of seoul instrumental activities of daily living (S-IADL). J Korean Neuropsychiatr Assoc. 2004;432:189-199.
23. Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412-2414. (Pubitemid 23346995)
24. Kang Y, Na DL. Seoul neuropsychological screening battery. In: Kang Y, Na DL, eds. Seoul Neuropsychological Screening Battery. Incheon: Human Brain Research & Consulting Co.; 2003:2-31.
25. Kim H, Na DL. Normative data on the Korean version of the Bostonnaming test. J Clin Exp Neuropsychol. 1999;21(1):127-133. (Pubitemid 29332001)
26. Scheltens P, Barkhof F, Leys D, et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci. 1993;114(1):7-12. (Pubitemid 23025201)
27. Bocti C, Swartz RH, Gao FQ, Sahlas DJ, Behl P, Black SE. A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia. Stroke. 2005;36(10): 2126-2131. (Pubitemid 41429232)
28. Scheltens P, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967-972.
29. Román GC. Lacunar dementia. In: Hutton JT, Kenny AD, ed. Senile Dementia of the Alzheimer Type. New York, NY: Alan R. Liss Inc.; 1985: 131-151.
30. Bierer LM, Haroutunian V, Gabriel S, et al. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem. 1995; 64(2):749-760.
31. Narumi S, Kiyota Y, Nagaoka A. Cerebral embolization impairs memory function and reduces cholinergic marker enzyme activities in various brain regions in rats. Pharmacol Biochem Behav. 1986;24(6):1729-1731. (Pubitemid 16066641)
32. Ogawa N, Asanuma M, Tanaka K, et al. Long-term time course of regional changes in cholinergic indices following transient ischemia in the spontaneously hypertensive rat brain. Brain Res. 1996; 712(1):60-68. (Pubitemid 26098780)
33. Haense C, Kalbe E, Herholz K, et al. Cholinergic system function and cognition in mild cognitive impairment. Neurobiol Aging. 2010;33(5):867-877.
34. Kim SH, Seo SW, Yoon DS, et al. Comparison of neuropsychological and FDG-PET findings between early-versus late-onset mild cognitive impairment: a five-year longitudinal study. Dement Geriatr Cogn Disord. 2010;29(3):213-223.
35. Rozzini L, Chilovi BV, Conti M, et al. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration. Int J Geriatr Psychiatry. 2007;22(12):1217-1222. (Pubitemid 350285426)
36. Hodges JR, Erzinclioglu S, Patterson K. Evolution of cognitive deficits and conversion to dementia in patients with mild cognitive impairment: a very-long-term follow-up study. Dement Geriatr Cogn Disord. 2006;21(5-6):380- 391. (Pubitemid 43735683)
37. DeKosky ST, Ikonomovic MD, Styren SD, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol. 2002;51(2):145-155. (Pubitemid 34111436)
38. Roher AE, Esh C, Rahman A, Kokjohn TA, Beach TG. Atherosclerosis of cerebral arteries in Alzheimer disease. Stroke. 2004; 35(11 suppl 1):2623-2627. (Pubitemid 39458353)
39. Roher AE, Esh C, Kokjohn TA, et al. Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler Thromb Vasc Biol. 2003;23(11):2055-2062. (Pubitemid 37433200)